SCPS Scopus BioPharma
- 0.000300
- 0.0000000.00%
Scopus BioPharma News
Scopus BioPharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-Armistice Capital, LLC(9.96%),Steven Boyd(9.96%)
Scopus BioPharma | D: Filing D
Scopus BioPharma | SC 13D: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities
Scopus BioPharma | 4: Statement of changes in beneficial ownership of securities
Scopus BioPharma | 4: Statement of changes in beneficial ownership of securities
Scopus BioPharma | SC 13D/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities (Amendment)
Scopus BioPharma | SC 13D/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities (Amendment)
Scopus BioPharma | 4: Statement of changes in beneficial ownership of securities
Scopus BioPharma | 3: Initial statement of beneficial ownership of securities
Scopus BioPharma | 4: Statement of changes in beneficial ownership of securities
Scopus BioPharma | 4: Statement of changes in beneficial ownership of securities
Scopus BioPharma | 4: Statement of changes in beneficial ownership of securities
Scopus BioPharma | 4: Statement of changes in beneficial ownership of securities
Scopus BioPharma | 4: Statement of changes in beneficial ownership of securities
Scopus BioPharma | 4: Statement of changes in beneficial ownership of securities
Scopus BioPharma | SC 13D: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities
Scopus BioPharma | SC 13D: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities
Scopus BioPharma | 4: Statement of changes in beneficial ownership of securities
Scopus BioPharma | 4: Statement of changes in beneficial ownership of securities
Scopus BioPharma | 4: Statement of changes in beneficial ownership of securities
Analysis
Price Target
No Data
No Data